Zobrazeno 1 - 10
of 128
pro vyhledávání: ''
Autor:
Miguel Paja-Fano, Fernando Guerrero-Pérez, Juan J. Díez, Diana Ariadel Cobo, José Manuel Cabezas Agrícola, Javier Gavira, I. Peiró, Idoia Genua, Susan M. Webb, Manuel Mateu-Salat, Betina Biagetti, Pedro Iglesias, Antía Fernández Pombo, Mariona Riudavets, Carlos García Gómez, Carles Villabona, Cristina Lamas, Margarita Majem
Publikováno v:
ENDOCRINE-RELATED CANCER
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Central adrenal insufficiency (AI) due to isolated adrenocorticotropic hormone (ACTH) deficiency (IAD) has been recently associated with immune checkpoint inhibitor (ICI) therapy. Our aim was to analyze the prevalence, clinical characteristics, and t
Autor:
Aline Guillot, Thierry Thomas, Wafa Bouleftour, K. Boussoualim, Nicolas Magné, Cécile Vassal, Sandrine Sotton
Publikováno v:
Endocrine-Related Cancer. 28:T39-T49
Prostate cancer (Pca) is the most commonly diagnosed cancer affecting men in France. Before the age of 75 years old, 1 in 8 French men will have Pca. Androgen deprivation therapies (ADT) remain the standard of care. Such therapies induce significant
Autor:
Patricia Niccoli, Flora Poizat, David Romano, Marie Lagarde, Sandrine Oziel-Taieb, Catherine Roche, Vincent Garcia, Anne Barlier, Corinne Gerard
Publikováno v:
Endocrine-Related Cancer
Endocrine-Related Cancer, BioScientifica, 2021, 28 (1), pp.39-51. ⟨10.1530/ERC-19-0142⟩
Endocrine-Related Cancer, BioScientifica, 2021, 28 (1), pp.39-51. ⟨10.1530/ERC-19-0142⟩
International audience; Although there is evidence of a significant rise of neuroendocrine neoplasms (NENs) incidence, current treatments are largely insufficient due to somewhat poor knowledge of these tumours. Despite showing differentiated feature
Autor:
Bruna Pilan, Ana Claudia Latronico, Antonio Lerario, Anna Flavia Figueredo Benedetti, Victor Srougi, Luciano F. Drager, Leticia A P Vilela, Tatiana S Goldbaum, Luiz Aparecido Bortolotto, Berenice B. Mendonca, Marcela Rassi-Cruz, Maria Adelaide Albergaria Pereira, Fabio R. Faucz, Lucas Santos de Santana, Aline C B S Cavalcante, Fabio Y Tanno, Jose Luis Chambo, Andrea Gutierrez Maria, Maria Candida Barisson Villares Fragoso, Francisco Cesar Carnevale, Maria Claudia Nogueira Zerbini, Edra London, Madson Q. Almeida, Constantine A. Stratakis
Publikováno v:
Endocr Relat Cancer
Familial primary aldosteronism (PA) is rare and mostly diagnosed in early-onset hypertension (HT). However, ‘sporadic’ bilateral adrenal hyperplasia (BAH) is the most frequent cause of PA and remains without genetic etiology in most cases. Our ai
Autor:
Cihan Kaya, Alyaksandr V. Nikitski, Vincenzo Condello, Marina N. Nikiforova, Abigail I. Wald, Simion I. Chiosea, Yuri E. Nikiforov, Federica Panebianco, Linwah Yip
Publikováno v:
Endocr Relat Cancer
ALK fusions are found in various tumors, including thyroid cancer, and serve as a diagnostic marker and therapeutic target. Spectrum and outcomes of ALK fusions found in thyroid nodules and cancer are not fully characterized. We report a series of 44
Autor:
Nicolle Besselink, Pier Selenica, Pjotr Prins, Britta Weigelt, Bert van der Vegt, Cathy B. Moelans, Peter Bult, Carmen C. van der Pol, Marco J. Koudijs, Marlous Hoogstraat, Robert Kornegoor, Jorge S. Reis-Filho, Paul J. van Diest, Natalie D. ter Hoeve, Isaac J. Nijman, Elsken van der Wall, Edwin Cuppen, Emile E. Voest, John W.M. Martens, Petra van der Groep, Wendy W.J. de Leng, Joep de Ligt, Miangela M. Lacle, Ellis Barbé, Vincent T.H.B.M. Smit
Publikováno v:
Endocr Relat Cancer
Endocrine-Related Cancer, 26(10), 779-794. Society for Endocrinology
Endocrine-Related Cancer, 26(10), 779. Society for Endocrinology
Endocrine-Related Cancer, 26(10), 779-794. Bioscientifica Ltd
Endocrine-Related cancer, 26(10), 779-794. BIOSCIENTIFICA LTD
Moelans, C B, de Ligt, J, van der Groep, P, Prins, P, Besselink, N J M, Hoogstraat, M, ter Hoeve, N D, Lacle, M M, Kornegoor, R, van der Pol, C C, de Leng, W W J, Barbé, E, van der Vegt, B, Martens, J, Bult, P, Smit, V T H B M, Koudijs, M J, Nijman, I J, Voest, E E, Selenica, P, Weigelt, B, Reis-Filho, J S, van der Wall, E, Cuppen, E & van Diest, P J 2019, ' The molecular genetic make-up of male breast cancer ', Endocrine-Related Cancer, vol. 26, no. 10, pp. 779-794 . https://doi.org/10.1530/ERC-19-0278
Endocrine-Related Cancer, 26(10), 779-794. Society for Endocrinology
Endocrine-Related Cancer, 26(10), 779. Society for Endocrinology
Endocrine-Related Cancer, 26(10), 779-794. Bioscientifica Ltd
Endocrine-Related cancer, 26(10), 779-794. BIOSCIENTIFICA LTD
Moelans, C B, de Ligt, J, van der Groep, P, Prins, P, Besselink, N J M, Hoogstraat, M, ter Hoeve, N D, Lacle, M M, Kornegoor, R, van der Pol, C C, de Leng, W W J, Barbé, E, van der Vegt, B, Martens, J, Bult, P, Smit, V T H B M, Koudijs, M J, Nijman, I J, Voest, E E, Selenica, P, Weigelt, B, Reis-Filho, J S, van der Wall, E, Cuppen, E & van Diest, P J 2019, ' The molecular genetic make-up of male breast cancer ', Endocrine-Related Cancer, vol. 26, no. 10, pp. 779-794 . https://doi.org/10.1530/ERC-19-0278
Male breast cancer (MBC) is extremely rare and accounts for less than 1% of all breast malignancies. Therefore, clinical management of MBC is currently guided by research on the disease in females. In this study, DNA obtained from 45 formalin-fixed p
Autor:
Guido Di Dalmazi, Valentina Vicennati, Uberto Pagotto, Francesca Ambrosi, Beatrice Rubin, Valeria Maffeis, Francesco Fallo, Sofia Asioli, Luca Morandi, Donatella Santini, Catia Pilon, Ambrogio Fassina, Antonio De Leo
Publikováno v:
Yearbook of Paediatric Endocrinology.
Context DNA methylation has been identified among putative regulatory mechanisms for CYP11B2 expression in primary aldosteronism. Objective The objective of this work is to investigate DNA methylation and expression of genes encoding steroidogenic en
Autor:
Donna C. Ferguson, Vivian L. Weiss, Kim Ely, Kensey N. Bergdorf, Thomas Stricker, Mitra Mehrad
Publikováno v:
Endocr Relat Cancer
The prevalence of thyroid carcinoma is increasing and represents the most common endocrine malignancy, with papillary thyroid carcinoma (PTC) being the most frequent subtype. The genetic alterations identified in PTCs fail to distinguish tumors with
Autor:
Ah Reum Oh, Kyu Eun Lee, Young Shin Song, Su Jin Kim, Gyeongseo Jung, Ji-Young Cha, Hwan Hee Kim, Seong Keun Yoo, Sun Wook Cho, Jeong-Sun Seo, Young Joo Park
Publikováno v:
Endocrine-Related Cancer. 26:629-641
Synergistic effects of BRAFV600E and TERT promoter mutations on the poor clinical outcomes in papillary thyroid cancer (PTC) have been demonstrated. The potential mechanism of this phenomenon has been proposed: MAPK pathway activation by the BRAFV600
Autor:
Brendan M. Finnerty, Rasa Zarnegar, Irene M. Min, Yi-Chieh Nancy Du, Olivier Elemento, Zhengming Chen, Akanksha Verma, Marco Seandel, Anna Aronova, Dean P. Edwards, Theresa Scognamiglio, Maureen D. Moore, Shixia Huang, Thomas J. Fahey
Publikováno v:
Endocrine-Related Cancer. 26:411-423
Loss of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) expression by CpG promoter hypermethylation is associated with metastasis in gastroenteropancreatic neuroendocrine tumors; however, the mechanism of how UCHL1 loss contributes to metastatic pot